Literature DB >> 20619785

Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds.

Thomas Gros1, Jeff S Sakamoto, Armin Blesch, Leif A Havton, Mark H Tuszynski.   

Abstract

Previously we reported that templated agarose scaffolds can orient and guide local spinal cord axons after injury. In the present study we examined whether growth of long-projecting spinal cord axons could also be promoted into, and then beyond, templated agarose scaffolds placed into a spinal cord lesion site. Ascending spinal cord dorsal column sensory axons were transected at the C4 level. Animals were then subjected to combinatorial therapies consisting of: 1) templated agarose scaffolds implanted into the lesion site, seeded with autologous bone marrow stromal cells expressing a growth factor, neurotrophin-3 (NT-3), 2) lentiviral vectors expressing NT-3 beyond the lesion site (to promote axonal emergence from the scaffold along chemotropic gradients of growth factors), and 3) priming lesions ("conditioning lesions") of the sensory neuronal cell body to stimulate the endogenous growth state of the injured neuron. Control groups received either non-organized, NT-3-expressing cell suspension grafts in the lesion site, or templated scaffolds plus one of the two components of the combination therapy. Among groups that received templated agarose scaffolds, long-tract sensory axonal regeneration occurred into the spinal cord lesion site, and the growth of these axons was remarkably organized and linear compared to non-organized cell suspension grafts. Axonal penetration was maximal in subjects that received combination therapies; further, 83 + 13% of axons entering the scaffolds in combination-treated subjects continued to grow the full length of the lesion cavity to reach the distal aspect of the scaffold, over a 2 mm distance. In contrast, axons regenerating into cell suspension grafts lacking guidance scaffolds exhibited a parabolic decay of growth as a function of distance, and only 22 + 6% of axons extended the length of the lesion cavity. Moreover, axonal regeneration beyond the lesion site occurred only among subjects that received full combinatorial treatments (p < 0.05). However, axon growth beyond the scaffold was constrained to a reactive cell layer that formed between the distal aspect of the scaffold and host tissue, and did not continue further to re-penetrate the host spinal cord. Thus, templated agarose scaffolds substantially enhance the organization and distance over which long-tract axons extend through a spinal cord lesion site in the presence of combinatorial therapies, but host-scaffold reactive interfaces limit axon re-penetration of the host. Further development must reduce reactive cellular interfaces to support effective axonal penetration of host parenchyma. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619785     DOI: 10.1016/j.biomaterials.2010.04.035

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  52 in total

1.  3D Printed Stem-Cell Derived Neural Progenitors Generate Spinal Cord Scaffolds.

Authors:  Daeha Joung; Vincent Truong; Colin C Neitzke; Shuang-Zhuang Guo; Patrick J Walsh; Joseph R Monat; Fanben Meng; Sung Hyun Park; James R Dutton; Ann M Parr; Michael C McAlpine
Journal:  Adv Funct Mater       Date:  2018-08-09       Impact factor: 18.808

2.  The Impact of Prestretch Induced Surface Anisotropy on Axon Regeneration.

Authors:  Chun Liu; Ryan Pyne; Jungsil Kim; Neil Thomas Wright; Seungik Baek; Christina Chan
Journal:  Tissue Eng Part C Methods       Date:  2016-01-08       Impact factor: 3.056

Review 3.  Axon Guidance Molecules and Neural Circuit Remodeling After Spinal Cord Injury.

Authors:  Edmund R Hollis
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

4.  Combinatorial tissue engineering partially restores function after spinal cord injury.

Authors:  Jeffrey S Hakim; Brian R Rodysill; Bingkun K Chen; Ann M Schmeichel; Michael J Yaszemski; Anthony J Windebank; Nicolas N Madigan
Journal:  J Tissue Eng Regen Med       Date:  2019-03-20       Impact factor: 3.963

Review 5.  Biomaterial-based interventions for neuronal regeneration and functional recovery in rodent model of spinal cord injury: a systematic review.

Authors:  Vibhor Krishna; Sanjay Konakondla; Joyce Nicholas; Abhay Varma; Mark Kindy; Xuejun Wen
Journal:  J Spinal Cord Med       Date:  2013-05       Impact factor: 1.985

6.  Comparison of cellular architecture, axonal growth, and blood vessel formation through cell-loaded polymer scaffolds in the transected rat spinal cord.

Authors:  Nicolas N Madigan; Bingkun K Chen; Andrew M Knight; Gemma E Rooney; Eva Sweeney; Lisa Kinnavane; Michael J Yaszemski; Peter Dockery; Timothy O'Brien; Siobhan S McMahon; Anthony J Windebank
Journal:  Tissue Eng Part A       Date:  2014-08-11       Impact factor: 3.845

7.  Spinal Progenitor-Laden Bridges Support Earlier Axon Regeneration Following Spinal Cord Injury.

Authors:  Courtney M Dumont; Mary K Munsell; Mitchell A Carlson; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2018-10-19       Impact factor: 3.845

8.  In Vivo Microcomputed Tomography of Nanocrystal-Doped Tissue Engineered Scaffolds.

Authors:  Stacey M Forton; Matthew T Latourette; Maciej Parys; Matti Kiupel; Dena Shahriari; Jeff S Sakamoto; Erik M Shapiro
Journal:  ACS Biomater Sci Eng       Date:  2016-02-29

Review 9.  Axon regeneration and exercise-dependent plasticity after spinal cord injury.

Authors:  John D Houle; Marie-Pascale Côté
Journal:  Ann N Y Acad Sci       Date:  2013-03       Impact factor: 5.691

10.  Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.

Authors:  Rodolfo E Gámez Sazo; Katsumi Maenaka; Weiyong Gu; Patrick M Wood; Mary Bartlett Bunge
Journal:  Biomaterials       Date:  2012-08-17       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.